Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cibele Nicolaski Pedron

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Chemical Biology & Drug Design|October 19, 2017
Anticancer activity of VmCT1 analogs against MCF-7 cellsCibele Nicolaski Pedron, Gislaine Patricia Andrade, Roseli Hiromi Sato, et al.
European Journal of Medicinal Chemistry|December 3, 2016
Novel designed VmCT1 analogs with increased antimicrobial activityCibele Nicolaski Pedron, Marcelo Der Torossian Torres, Julia Aparecida da Silva Lima, et al.
Bioorganic Chemistry|June 19, 2019
Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogensCibele Nicolaski Pedron, Iris Araújo, Pedro Ismael da Silva Junior, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 11, 2017
Antimicrobial activity of leucine-substituted decoralin analogs with lower hemolytic activityMarcelo Der Torossian Torres, Cibele Nicolaski Pedron, Julia Aparecida da Silva Lima, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|November 19, 2017
Generation of Advanced Glycation End-Products (AGEs) by glycoxidation mediated by copper and ROS in a human serum albumin (HSA) model peptide: reaction mechanism and damage in motor neuron cellsCaroline Martins Sandanielo Marques, Emilene Arusievicz Nunes, Larissa Lago, et al.
ACS Infectious Diseases|August 31, 2021
Synthetic Peptide Derived from Scorpion Venom Displays Minimal Toxicity and Anti-infective Activity in an Animal ModelCyntia Silva Oliveira, Marcelo Der Torossian Torres, Cibele Nicolaski Pedron, et al.
Parasitology|October 2, 2020
Arg-substituted VmCT1 analogs reveals promising candidate for the development of new antichagasic agentCibele Nicolaski Pedron, Katielle Albuquerque Freire, Marcelo Der Torossian Torres, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
The BR2 peptide associated with 2-aminoethyl dihydrogen phosphate is a formulation with antiproliferative potential for a triple-negative breast cancer modelLaertty Garcia de Sousa Cabral, Henrique Hesse, Katielle Albuquerque Freire, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 14, 2021
Net charge tuning modulates the antiplasmodial and anticancer properties of peptides derived from scorpion venomCibele Nicolaski Pedron, Adriana Farias Silva, Marcelo Der Torossian Torres, et al.
Journal of Microbiology and Biotechnology|September 30, 2024
Evaluating the Antimicrobial Efficacy of a Designed Synthetic peptide against Pathogenic BacteriaMaria Caroline de Moura Cavalheiro, Caio Fernando Ramalho de Oliveira, Ana Paula de Araújo Boleti, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chemical Biology & Drug Design|October 19, 2017
Anticancer activity of VmCT1 analogs against MCF-7 cellsCibele Nicolaski Pedron, Gislaine Patricia Andrade, Roseli Hiromi Sato, et al.
European Journal of Medicinal Chemistry|December 3, 2016
Novel designed VmCT1 analogs with increased antimicrobial activityCibele Nicolaski Pedron, Marcelo Der Torossian Torres, Julia Aparecida da Silva Lima, et al.
Bioorganic Chemistry|June 19, 2019
Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogensCibele Nicolaski Pedron, Iris Araújo, Pedro Ismael da Silva Junior, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 11, 2017
Antimicrobial activity of leucine-substituted decoralin analogs with lower hemolytic activityMarcelo Der Torossian Torres, Cibele Nicolaski Pedron, Julia Aparecida da Silva Lima, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|November 19, 2017
Generation of Advanced Glycation End-Products (AGEs) by glycoxidation mediated by copper and ROS in a human serum albumin (HSA) model peptide: reaction mechanism and damage in motor neuron cellsCaroline Martins Sandanielo Marques, Emilene Arusievicz Nunes, Larissa Lago, et al.
ACS Infectious Diseases|August 31, 2021
Synthetic Peptide Derived from Scorpion Venom Displays Minimal Toxicity and Anti-infective Activity in an Animal ModelCyntia Silva Oliveira, Marcelo Der Torossian Torres, Cibele Nicolaski Pedron, et al.
Parasitology|October 2, 2020
Arg-substituted VmCT1 analogs reveals promising candidate for the development of new antichagasic agentCibele Nicolaski Pedron, Katielle Albuquerque Freire, Marcelo Der Torossian Torres, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
The BR2 peptide associated with 2-aminoethyl dihydrogen phosphate is a formulation with antiproliferative potential for a triple-negative breast cancer modelLaertty Garcia de Sousa Cabral, Henrique Hesse, Katielle Albuquerque Freire, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 14, 2021
Net charge tuning modulates the antiplasmodial and anticancer properties of peptides derived from scorpion venomCibele Nicolaski Pedron, Adriana Farias Silva, Marcelo Der Torossian Torres, et al.
Journal of Microbiology and Biotechnology|September 30, 2024
Evaluating the Antimicrobial Efficacy of a Designed Synthetic peptide against Pathogenic BacteriaMaria Caroline de Moura Cavalheiro, Caio Fernando Ramalho de Oliveira, Ana Paula de Araújo Boleti, et al.
Pageof 2